We are international
Donate
TEXT SIZE   


ASH 2012: Dr. Pawlyn - Sequential Immunomodulatory Drug (IMiD) and Proteosome Inhibitor Therapy Improves Response Rates in Newly Diagnosed Multiple Myeloma: Preliminary Results From the Myeloma XI Trial
Charlotte Pawlyn, MD
Institute of Cancer Research
Sutton, United Kingdom
12.03.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles